Savencia (SAVE) Q1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 TU earnings summary
23 Apr, 2026Executive summary
Revenue for Q1 2026 reached €1,629 million, down 0.4% on a comparable basis and 3.9% on a reported basis, mainly due to unfavorable exchange rates, especially the Argentine peso and Asian currencies.
Cheese Products saw a 1.4% decline on a comparable basis, with resilience in volumes and mix, but negative price and milk price effects.
Other Dairy Products grew 0.3% on a comparable basis, driven by positive ingredient volumes, offsetting declines in commodity prices and butter.
Financial highlights
Total sales: €1,629 million for Q1 2026, compared to €1,695 million in Q1 2025.
Cheese Products sales: €932 million (57.2% of total), down from €953 million (56.2%) year-over-year.
Other Dairy Products sales: €752 million (46.1% of total), down from €805 million (47.5%) year-over-year.
Unallocated items: -€55 million, improved from -€63 million year-over-year.
Outlook and guidance
2026 outlook remains uncertain due to geopolitical tensions, economic slowdown, and potential inflation from Middle East crisis.
Group continues specialty strategy, competitiveness efforts, and investments in business complementarity and brand growth, including chocolate activities.
Latest events from Savencia
- Organic growth of 1.6% offset currency-driven sales decline, with strong CSR progress.SAVE
H2 20255 Mar 2026 - Revenue up 0.5%, but profit fell amid cost inflation, currency headwinds, and merger plans.SAVE
H1 202522 Sep 2025 - Stable revenue and improved net income, with strong international dairy performance.SAVE
H1 202413 Jun 2025 - Stable Q1 2025 revenue as dairy inflation and currency volatility shape cautious outlook.SAVE
Q1 2025 TU6 Jun 2025 - 2024 sales rose 5.1%, driven by Other Dairy Products and international market gains.SAVE
Q4 2024 TU6 Jun 2025 - Savencia achieved 5.1% sales growth and higher margins, proposing a €1.60 dividend per share.SAVE
H2 20246 Jun 2025